Navigation Links
MicroCHIPS Announces 35th U.S. Patent for Microreservoir-Based Drug Delivery Systems
Date:3/29/2011

WALTHAM, Mass., March 29, 2011 /PRNewswire/ -- MicroCHIPS, Inc., a developer of innovative drug delivery devices and biosensors, today announced that the U.S. Patent Office and Trademark Office has granted U.S. Patent No. 7,892,221, Method of Controlled Drug Delivery from Implant Device. This patent in conjunction with U.S. Patent No. 7,070,590 provides broad coverage for the design and fabrication of reservoir-based medical devices used for implantable drug delivery systems.

MicroCHIPS' intellectual property originated as patent filings at the Massachusetts Institute of Technology, by professors and MicroCHIPS cofounders Robert Langer and Michael Cima, and cofounder John Santini. These patents are licensed to MicroCHIPS, which has continued to develop and enhance the reservoir-based technology and to generate additional intellectual property covering microreservoirs, controlled release components and systems, and biosensors. As a result, MicroCHIPS' current patent portfolio includes more than 80 patents and more than 50 pending applications, covering the U.S., Canada, various countries in Europe and Asia, as well as Australia.

"The granting of this patent provides the fundamental building blocks for programmable medical drug delivery implants to address various diseases such as diabetes, osteoporosis, heart disease, and cancer," said Robert Langer, ScD, Institute Professor at the David H. Koch Institute for Integrative Cancer Research at MIT.

MicroCHIPS' miniaturized systems are adaptable to implants and catheters as well as on-body delivery systems, external pumps, pens and infusion systems. Currently, the MicroCHIPS technology is embodied in the company's medical implants that are part of a clinical trial to treat osteoporosis in women. The trial is evaluating the pharmacokinetics of precise delivery of human parathyroid hormone (hPTH 1-34) from a programmable, wireless implanted device.

"This patent and technology portfolio combined with the on-going MicroCHIPS clinical trial focused on delivery of human parathyroid hormone will demonstrate the viability of controlled release from programmable or pre-programmable devices," said Michael Cima, PhD, the Sumitomo Electric Industries Professor of Engineering at the David H. Koch Institute for Integrative Cancer Research at MIT.

About MicroCHIPS

MicroCHIPS, Inc. is pioneering programmable implanted devices designed to improve the health of millions of people with critical conditions that require careful monitoring and therapy. MicroCHIPS' technologies enable the creation of in- and on-body devices that can sense vital biochemical changes, deliver potent drug therapies and communicate using wireless technologies. The technologies use microreservoir arrays to hermetically store and protect pharmaceuticals or sensors for extended periods of time. The reservoir arrays are compatible with microprocessors, wireless communications and sensor feedback loops to provide precise, dynamic control of delivery or sensing.


'/>"/>
SOURCE MicroCHIPS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MicroCHIPS Named 2010 Technology Pioneer by World Economic Forum
2. MEDRAD® Announces New Head of Interventional Business
3. Sanofi-aventis Announces Registration Statement for CVR Related to Genzyme Acquisition Declared Effective
4. WaferGen Announces Data Presentations From Newly Launched High-Throughput SmartChip Human microRNA Panel V2 at Scientific Conferences, Including AACR
5. Boston Scientific Announces Its ACC 2011 Schedule
6. Tris Pharma Announces Availability of the MyKidz® Iron Product Line - the Best Tasting Iron Supplements
7. Dendreon Announces Webcast Presentations at Upcoming Conferences
8. Diversified Medical Equipment & Supplies Corporation Announces New Home Care Medical Supply Division
9. Regado Biosciences, Inc. Announces Presentation of the Results of the RADAR Phase 2b Clinical Trial of Its Anticoagulant System REG1 at the i2 Summit During the American College of Cardiology 2011 60th Annual Scientific Session & Expo in New Orleans
10. JHP Pharmaceuticals Announces Multi-Year Contract Manufacturing Agreement
11. Ascension Orthopedics Announces Market Release of TITAN™ Modular Shoulder Fracture Prosthesis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... CHAPEL HILL, N.C. , June 24, 2016 ... in healthcare decisions and regulators/payers have placed more ... this new environment, patient support programs in the ... support for patients, medications. Consequently, pharmaceutical companies are ... to ensure they are providing products and services ...
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... 2016 Dublin ... addition of the " Global Markets for Spectroscopy ... This report focuses on the ... review, including its applications in various applications. The report ... includes three main industries: pharmaceutical and biotechnology, food and ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users ... - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 ... Pro X . Simply select a ProHand generator and drag it above media or ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
Breaking Medicine News(10 mins):